Biocompatibility Innovation
Biostealth Technology Platform for
Medical Devices
BCI develops technologies engineered to enhance medical device biocompatibility and extend device lifespan, while preserving full functionality.
Adverse biological reactions to medical devices remain a major contributor to device failure and patient complications.
BCI’s technology platform uses plant-derived molecules to target the biological processes that contribute to premature device deterioration and failure, supporting improved long-term clinical management.
By improving device biocompatibility and durability, BCI’s technologies can help reduce the need for repeat interventions and improve patients’ quality of life.
Biostealth Technology
Our ultra-thin, non-eluting biostealth technologies permanently bond with the materials used in medical devices without altering their original physical or functional properties.
These plant-based add-on technologies are designed for scalable integration into medical device manufacturing.
Each patented solution creates a protective interface intended to inhibit inflammation, calcification, thrombosis, infection, and immune-mediated reactions.
BCI’s proprietary platform offers tailored solutions for a broad range of medical device materials and clinical applications.
One Platform. Multiple Solutions.
Our Solutions
A proprietary platform engineered for diverse materials and medical applications, adaptable to specific clinical and manufacturing needs.
Barrier Against Failure
BCI technologies are built to limit the post-implant biological processes that contribute to device degeneration, supporting durable device function over time.
Partnerships
